|

Empagliflozin 10 MG Clinical Trials

16 actively recruiting trials across 3 locations

Also known as: Horizon,, Jardiance, Jardiance 10 Mg, Jardiance, Empagliflozin, Jardiance®

Pipeline

Phase 1: 1Phase 2: 4Phase 3: 2Phase 4: 7Phase 2/3: 2

Top Sponsors

  • Yale University2
  • China National Center for Cardiovascular Diseases2
  • University of East Anglia1
  • University Medical Centre Ljubljana1
  • Seoul National University Bundang Hospital1

Indications

  • Heart Disease10
  • Diabetes5
  • Heart Failure3
  • Liver Disease2
  • Pre-Heart Failure1

Other12 trials

A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Phase 4
Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease
Phase 2
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
Phase 3
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
Phase 4
Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
Phase 4
Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
Phase 4
Empagliflozin for No-reflow Phenomenon in PCI for STEMI
Phase 2
Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
Phase 3
The EMPA-FIT Study
Phase 4
The Role of SGLT2i in Management of Moderate AS
Phase 2/3
The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Phase 2/3
Use of SGLT2i in noHCM With HFpEF
Phase 4

New Haven, Connecticut2 trials

Effects of Acute and Chronic Empagliflozin Heart Failure

Yale New Haven Hospital

Phase 1
Empagliflozin in Patients With Cirrhosis and Ascites

Yale University

Phase 2

Chicago, Illinois1 trial

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2

Pittsburgh, Pennsylvania1 trial

Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease

Magee Women's Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.